Ikarian Capital reported a 4.2% stake in InMed Pharmaceuticals INM · 137,634 sh · passive holder

Trade details

Type: 5% stake report
Report: 13G passive
Stake: 4.2%
Last report: First report
Shares held: 137,634 sh
Class: Common Shares, no par value
Stock: InMed Pharmaceuticals INM
Holder: Ikarian Capital
Event date: 26/06/30
Filed: 26/08/14

4.2% stake · below 5%

InMed Pharmaceuticals trades, last 26 weeks

What else happened in InMed Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 05/31~07/30

Ikarian Capital's other 5% stake reports

Ikarian Capital
5% stakeCNS Pharmaceuticals
5% stake
CNS Pharmaceuticals
CNSP
9.9% stake
147,290 sh
9.9% stake
Filed 08/14
Ikarian Capital
5% stakeConnect Biopharma Holdings
5% stake
Connect Biopharma Holdings
CNTB
6.9% stake
4,338,534 sh
6.9% stake
Filed 08/14
Ikarian Capital
5% stakeQuince Therapeutics
5% stake
Quince Therapeutics
QNCX
9% stake
91,789 sh
9% stake
Filed 08/14
Ikarian Capital
5% stakeTenax Therapeutics
5% stake
Tenax Therapeutics
TENX
2.9% stake
1,080,700 sh
2.9% stake
Filed 08/14
Ikarian Capital
5% stakeKazia Therapeutics
5% stake
Kazia Therapeutics
KZIA
4.9% stake
575,778 sh
4.9% stake
Filed 08/14